[TOPGLOV] QoQ TTM Result on 31-Aug-2021 [#4]

Announcement Date
17-Sep-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Aug-2021
Quarter
31-Aug-2021 [#4]
Profit Trend
QoQ- -7.98%
YoY- 322.54%
View:
Show?
TTM Result
31/05/22 28/02/22 30/11/21 31/08/21 31/05/21 28/02/21 30/11/20 CAGR
Revenue 6,614,452 9,312,552 13,228,737 16,403,870 17,396,595 14,922,175 10,786,470 -27.84%
PBT 1,139,025 3,704,142 7,316,861 10,153,541 11,047,579 8,866,093 5,271,473 -64.02%
Tax -173,585 -703,551 -1,516,899 -2,150,763 -2,350,244 -1,883,151 -1,074,226 -70.36%
NP 965,440 3,000,591 5,799,962 8,002,778 8,697,335 6,982,942 4,197,247 -62.49%
-
NP to SH 896,506 2,917,379 5,698,807 7,888,864 8,572,912 6,884,642 4,131,348 -63.92%
-
Tax Rate 15.24% 18.99% 20.73% 21.18% 21.27% 21.24% 20.38% -
Total Cost 5,649,012 6,311,961 7,428,775 8,401,092 8,699,260 7,939,233 6,589,223 -9.76%
-
Net Worth 5,605,771 5,605,724 5,605,702 6,005,904 6,883,963 6,897,736 5,530,804 0.90%
Dividend
31/05/22 28/02/22 30/11/21 31/08/21 31/05/21 28/02/21 30/11/20 CAGR
Div 528,522 1,969,352 3,990,549 5,217,035 5,473,011 4,288,195 2,266,998 -62.15%
Div Payout % 58.95% 67.50% 70.02% 66.13% 63.84% 62.29% 54.87% -
Equity
31/05/22 28/02/22 30/11/21 31/08/21 31/05/21 28/02/21 30/11/20 CAGR
Net Worth 5,605,771 5,605,724 5,605,702 6,005,904 6,883,963 6,897,736 5,530,804 0.90%
NOSH 8,207,105 8,207,076 8,207,017 8,206,864 8,206,550 8,020,623 8,196,499 0.08%
Ratio Analysis
31/05/22 28/02/22 30/11/21 31/08/21 31/05/21 28/02/21 30/11/20 CAGR
NP Margin 14.60% 32.22% 43.84% 48.79% 49.99% 46.80% 38.91% -
ROE 15.99% 52.04% 101.66% 131.35% 124.53% 99.81% 74.70% -
Per Share
31/05/22 28/02/22 30/11/21 31/08/21 31/05/21 28/02/21 30/11/20 CAGR
RPS 82.60 116.29 165.19 204.85 217.33 186.05 134.57 -27.79%
EPS 11.19 36.43 71.16 98.51 107.10 85.84 51.54 -63.91%
DPS 6.60 24.60 49.80 65.10 68.20 53.46 28.28 -62.12%
NAPS 0.70 0.70 0.70 0.75 0.86 0.86 0.69 0.96%
Adjusted Per Share Value based on latest NOSH - 8,206,864
31/05/22 28/02/22 30/11/21 31/08/21 31/05/21 28/02/21 30/11/20 CAGR
RPS 80.59 113.47 161.19 199.87 211.97 181.82 131.43 -27.84%
EPS 10.92 35.55 69.44 96.12 104.46 83.89 50.34 -63.93%
DPS 6.44 24.00 48.62 63.57 66.69 52.25 27.62 -62.15%
NAPS 0.683 0.683 0.683 0.7318 0.8388 0.8405 0.6739 0.89%
Price Multiplier on Financial Quarter End Date
31/05/22 28/02/22 30/11/21 31/08/21 31/05/21 28/02/21 30/11/20 CAGR
Date 31/05/22 28/02/22 30/11/21 30/08/21 31/05/21 26/02/21 30/11/20 -
Price 1.40 2.05 2.93 4.00 5.18 5.24 7.12 -
P/RPS 1.70 1.76 1.77 1.95 2.38 2.82 5.29 -53.11%
P/EPS 12.51 5.63 4.12 4.06 4.84 6.10 13.81 -6.38%
EY 8.00 17.77 24.29 24.63 20.68 16.38 7.24 6.88%
DY 4.71 12.00 17.00 16.28 13.17 10.20 3.97 12.08%
P/NAPS 2.00 2.93 4.19 5.33 6.02 6.09 10.32 -66.54%
Price Multiplier on Announcement Date
31/05/22 28/02/22 30/11/21 31/08/21 31/05/21 28/02/21 30/11/20 CAGR
Date 09/06/22 09/03/22 10/12/21 17/09/21 09/06/21 09/03/21 09/12/20 -
Price 1.22 1.68 2.16 3.06 4.84 5.19 6.84 -
P/RPS 1.48 1.44 1.31 1.49 2.23 2.79 5.08 -56.08%
P/EPS 10.90 4.61 3.04 3.11 4.52 6.05 13.27 -12.30%
EY 9.18 21.68 32.95 32.19 22.13 16.54 7.54 14.03%
DY 5.41 14.64 23.06 21.27 14.09 10.30 4.13 19.73%
P/NAPS 1.74 2.40 3.09 4.08 5.63 6.03 9.91 -68.67%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment